Consolidation of image interpretation assistance into one package can minimize costs and open the market to radiology providers who cannot afford current offerings, scientists write in Radiology.
IRs can play a key role in kidney care using a novel, nonsurgical approach that deploys catheters and imaging guidance to create a fistula in the arm for dialysis access.
Robert C. O’Laughlin, MD, and attorneys first took Radiation Therapy Services and its physicians to court in late 2016, citing qui tam provisions of the False Claims Act.
Even before the onset of COVID-19, data suggested that rads’ after-hours workloads had doubled in proportion to the increase in emergency department visits in the years leading up to 2020.
The federal payment program first proposed this 2.5%, across-the-board cut for physician services in July, exempting most time-based healthcare offerings.
The findings come amid reports of a “major” workforce shortage in pediatric radiology, driven by decreased trainee interest in related fellowships, rising clinical volumes and a competitive job market.
Five years after Congress passed the landmark law, shortcomings persist, which are potentially hampering patients and physicians, House leaders contend.
Dutch imaging experts believe this new approach—letting artificial intelligence read cases only in which it is certain—could eventually serve as a solution to workforce shortages.
If explosive growth is a sure sign of astute planning, Sol Radiology has some of the best strategists in the business. As recently as late 2022, the Southern California practice had three radiologists serving one hospital. Today it’s a 45-physician force reading for 25 sites and running three of its own imaging centers.
Even before the onset of COVID-19, data suggested that rads’ after-hours workloads had doubled in proportion to the increase in emergency department visits in the years leading up to 2020.
“The explanation here is simple. Ultrasound gives you more information, and more concrete information, about what’s going on,” authors of a new JAMA study say.
“FDA clearance comes at the perfect time, with guidelines being adopted clinically for cardiac CT and with positive reimbursement driving procedure growth," says Jean-Luc Procaccini, CEO, molecular imaging and CT.
